Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

被引:25
|
作者
Li, Di [1 ,2 ,5 ,6 ]
Deng, Chaoqiang [1 ,2 ,5 ,6 ]
Wang, Shengping [4 ,5 ,6 ]
Li, Yuan [3 ,5 ,6 ]
Zhang, Yang [1 ,2 ,5 ,6 ]
Chen, Haiquan [1 ,2 ,5 ,6 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, 270 Dong An Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, State Key Lab Genet Engn, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, 270 Dong An Rd, Shanghai 200032, Peoples R China
[4] Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Med Coll, Inst Thorac Oncol, Shanghai, Peoples R China
[6] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
adenocarcinoma in situ; minimally invasive adenocarcinoma; prognosis; secondary primary lung cancer; sublobar resection; SECTION COMPUTED-TOMOGRAPHY; LIMITED-RESECTION; IASLC/ATS/ERS CLASSIFICATION; RANDOMIZED-TRIAL; LOBECTOMY; DIAGNOSIS; OUTCOMES; IMPACT; TUMORS;
D O I
10.1016/j.jtcvs.2022.06.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods: Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results: After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10- year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1%(41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions: Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.
引用
收藏
页码:1614 / +
页数:10
相关论文
共 50 条
  • [1] Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung
    Yotsukura, Masaya
    Asamura, Hisao
    Motoi, Noriko
    Kashima, Jumpei
    Yoshida, Yukihiro
    Nakagawa, Kazuo
    Shiraishi, Kouya
    Kohno, Takashi
    Yatabe, Yasushi
    Watanabe, Shun-ichi
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (08) : 1312 - 1320
  • [2] Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer
    Li, Xiongfei
    Fan, Fanfan
    Yang, Zijiang
    Huang, Qingyuan
    Fu, Fangqiu
    Zhang, Yang
    Chen, Haiquan
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 5729 - 5737
  • [3] Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer
    Niimi, Takahiro
    Samejima, Joji
    Wakabayashi, Masashi
    Miyoshi, Tomohiro
    Tane, Kenta
    Aokage, Keiju
    Taki, Tetsuro
    Nakai, Tokiko
    Ishii, Genichiro
    Kikuchi, Akitomo
    Yoshioka, Emi
    Yokose, Tomoyuki
    Ito, Hiroyuki
    Tsuboi, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (04) : 479 - 488
  • [4] Predictors of upstage and treatment strategies for stage IA lung cancers after sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma
    Su, Hang
    Gu, Chang
    She, Yunlang
    Xu, Long
    Yang, Ping
    Xie, Huikang
    Zhao, Shengnan
    Wu, Chunyan
    Xie, Dong
    Chen, Chang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 32 - +
  • [5] Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma
    Weichert, Wilko
    Warth, Arne
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (04) : 309 - 316
  • [6] Prognostic Significance of Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients With Stage I Disease
    Kadota, Kyuichi
    Villena-Vargas, Jonathan
    Yoshizawa, Akihiko
    Motoi, Noriko
    Sima, Camelia S.
    Riely, Gregory J.
    Rusch, Valerie W.
    Adusumilli, Prasad S.
    Travis, William D.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (04) : 448 - 460
  • [7] Clinicopathologic Features and Genetic Alterations in Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung: Long-Term Follow-Up Study of 121 Asian Patients
    Jia, Meng
    Yu, Shili
    Cao, Lanqing
    Sun, Ping-Li
    Gao, Hongwen
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (08) : 3052 - 3063
  • [8] A prospective ten-year follow-up of patients with chronic urticaria
    Dionigi, P. C. L.
    Menezes, M. C. S.
    Forte, W. C. N.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2016, 44 (04) : 286 - 291
  • [9] A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity
    Sagawa, Motoyasu
    Oizumi, Hiroyuki
    Suzuki, Hiroyuki
    Uramoto, Hidetaka
    Usuda, Katsuo
    Sakurada, Akira
    Chida, Masayuki
    Shiono, Satoshi
    Abe, Jiro
    Hasumi, Tohru
    Sato, Masami
    Sato, Nobuyuki
    Shibuya, Jotaro
    Deguchi, Hiroyuki
    Okada, Yoshinori
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 53 (04) : 849 - 856
  • [10] Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section
    Zhang, Yang
    Deng, Chaoqiang
    Fu, Fangqiu
    Ma, Zelin
    Wen, Zhexu
    Ma, Xiangyi
    Wang, Shengping
    Li, Yuan
    Chen, Haiquan
    CHEST, 2021, 159 (03) : 1265 - 1272